This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Lamotrigine - 25 mg
- Starting date:
- May 27, 2013
- Posting date:
- June 6, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety, Quality
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-33953
Recalled products
- Lamotrigine - 25 mg
Reason
Quality concerns at the manufacturing facility of the active ingredients used in the products.
Depth of distribution
Distributed to wholesalers / pharmacies across Canada
Affected products
A. Lamotrigine - 25 mg
DIN, NPN, DIN-HIM
DIN 02343010
Dosage form
- Tablets
Strength
- 25 mg
Lot or serial number
- 36005R
- 1039583
- 1041529
- 1055102
- 1071322
- 1090444
- 1101442
- 3003518
Companies
- Recalling Firm
-
Sanis Health Inc.
333 Champlain Street, Suite 102
Dieppe
E1A 1P2
New Brunswick
CANADA
- Marketing Authorization Holder
-
Sanis Health Inc.
333 Champlain Street, Suite 102
Dieppe
E1A 1P2
New Brunswick
CANADA